Literature DB >> 6400150

The role of progestins and progesterone receptors in the treatment of breast cancer.

S M Sedlacek, K B Horwitz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6400150     DOI： 10.1016/s0039-128x(84)80029-x

Source DB:  PubMed          Journal:  Steroids        ISSN： 0039-128X            Impact factor:   2.668


× No keyword cloud information.
  8 in total

Review 1.  Clinical pharmacokinetics of endocrine agents used in advanced breast cancer.

Authors:  P E Lønning; E A Lien; S Lundgren; S Kvinnsland
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

2.  The effects of cyclosporin A, tamoxifen, and medroxyprogesterone acetate on the enhancement of adriamycin cytotoxicity in primary cultures of human breast epithelial cells.

Authors:  J A Claudio; J T Emerman
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  Immunohistochemical analysis of the topographical relationship between the estrogen- and progesterone receptor in five human breast cancers. A simultaneous demonstration of both nuclear receptors in the same section by using a computer-assisted image processing.

Authors:  H Bonkhoff; N Wernert
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

Review 4.  Molecular biology of breast carcinoma.

Authors:  D el-Ashry; M E Lippman
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

Review 5.  Endocrine therapy for advanced breast cancer: a review.

Authors:  H B Muss
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

6.  Phase I clinical and pharmacokinetics study of high-dose toremifene in postmenopausal patients with advanced breast cancer.

Authors:  J Bishop; R Murray; L Webster; P Pitt; K Stokes; A Fennessy; I Olver; G Leber
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

7.  Megestrol acetate versus aminoglutethimide for metastatic breast cancer.

Authors:  S Lundgren; S Gundersen; R Klepp; P E Lønning; E Lund; S Kvinnsland
Journal:  Breast Cancer Res Treat       Date:  1989-11       Impact factor: 4.872

8.  Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancer.

Authors:  A Chang; G M Yousef; A Scorilas; L Grass; P Sismondi; R Ponzone; E P Diamandis
Journal:  Br J Cancer       Date:  2002-05-06       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.